MFIMFI
NEO icon

Mesirow Financial Investment Management - Fixed Income’s NeoGenomics NEO Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,190
Closed -$396K – 139
2017
Q1 		$396K Buy
50,190
+17,975
+56% +$146K 0.03% 125
2016
Q4 		$276K Buy
+32,215
New +$276K 0.02% 210

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Mesirow Financial Investment Management - Fixed Income's NEO Position: Q2 2017 in Review

Mesirow Financial Investment Management - Fixed Income sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 50,190 shares — an estimated $396K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in NEO in Q4 2016 and held it in 2 quarters. The position peaked at $396K in Q1 2017. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

  • Mesirow Financial Investment Management - Fixed Income reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
  • Mesirow Financial Investment Management - Fixed Income sold 50,190 NeoGenomics shares in Q2 2017, an estimated $396K.
  • Mesirow Financial Investment Management - Fixed Income first reported a position in NeoGenomics in Q4 2016 and held it in 2 quarters.
  • Mesirow Financial Investment Management - Fixed Income's NeoGenomics position peaked at $396K in Q1 2017.
  • 134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q2 2017, filed 1 Aug 2017.